Skip to Main Content

Author Details

Johnathan D Guest
2017
19
11
PMIDPaper TitleJournal TitlePublished Year
36877050Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.2023
37905971Impact of AlphaFold on structure prediction of protein complexes: The CASP15-CAPRI experiment.Proteins2023
37468530Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials.2023
35263223Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.Proc Natl Acad Sci U S A2022
34655573An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.Gastroenterology2022
35013235Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.Nat Commun2022
34491988Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.PLoS Comput Biol2021
33539768An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.Structure2021
34063143Structure-Based and Rational Design of a Hepatitis C Virus Vaccine.Viruses2021
32890396CoV3D: a database of high resolution coronavirus protein structures.Nucleic Acids Res2021
33431677Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.Proc Natl Acad Sci U S A2021
32577656CoV3D: A database and resource for high resolution coronavirus protein structures.bioRxiv2020
32878891Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization.J Virol2020
31100098Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.PLoS Pathog2019
31612567Blind prediction of homo- and hetero-protein complexes: The CASP13-CAPRI experiment.Proteins2019
30530224Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation.Virology2019
30651366Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells.J Virol2019
29892287Computational Modeling of Hepatitis C Virus Envelope Glycoprotein Structure and Recognition.Front Immunol2018
29253863Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.PLoS Pathog2017
  • 1 - 19 of 19

Recommended Authors

Collaborators

University of Maryland Institute for Bioscience and Biotechnology Research
Co-authored papers 15
Co-authored papers 5
VIB-VUB Center for Structural Biology
Co-authored papers 2
Co-authored papers 2
University of Missouri
Co-authored papers 2
King Abdullah University of Science and Technology (KAUST)
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Instituto de Ciencias de la Vid y del Vino (ICVV-CSIC)
Co-authored papers 2
Co-authored papers 2
Bijvoet Center for Biomolecular Research, Utrecht University
Co-authored papers 2
University Lille, CNRS
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
European Bioinformatics Institute
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Visterra Inc.
Co-authored papers 2
Dalton Cardiovascular Research Center, University of Missouri
Co-authored papers 2
Utrecht University
Co-authored papers 2
Co-authored papers 2
Boston University
Co-authored papers 2
GSK Medicines Research Centre
Co-authored papers 2
University of Massachusetts Medical School
Co-authored papers 2
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2